Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3524520010 | Product containing tositumomab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3716861018 | Tositumomab-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing tositumomab | Is a | Product containing monoclonal antibody | false | Inferred relationship | Existential restriction modifier | ||
| Product containing tositumomab | Has active ingredient | Tositumomab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing tositumomab | Has active ingredient | Immunosuppressant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing tositumomab | Is a | Medicinal product acting as antineoplastic agent (product) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing tositumomab | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing tositumomab | Is a | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial | Is a | False | Product containing tositumomab | Inferred relationship | Existential restriction modifier | |
| Product containing only tositumomab (medicinal product) | Is a | True | Product containing tositumomab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR